IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-10523-3.html
   My bibliography  Save this article

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia

Author

Listed:
  • Gerard Minuesa

    (Memorial Sloan-Kettering Cancer Center)

  • Steven K. Albanese

    (Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center)

  • Wei Xie

    (Memorial Sloan Kettering Cancer Center)

  • Yaniv Kazansky

    (Rockefeller University and Sloan Kettering Institute)

  • Daniel Worroll

    (Weill Cornell Graduate School of Medical Sciences)

  • Arthur Chow

    (Memorial Sloan-Kettering Cancer Center)

  • Alexandra Schurer

    (Memorial Sloan-Kettering Cancer Center)

  • Sun-Mi Park

    (Memorial Sloan-Kettering Cancer Center)

  • Christina Z. Rotsides

    (Memorial Sloan Kettering Cancer Center)

  • James Taggart

    (Memorial Sloan-Kettering Cancer Center)

  • Andrea Rizzi

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Levi N. Naden

    (Memorial Sloan Kettering Cancer Center)

  • Timothy Chou

    (Memorial Sloan-Kettering Cancer Center)

  • Saroj Gourkanti

    (Memorial Sloan-Kettering Cancer Center)

  • Daniel Cappel

    (Schrödinger GmbH)

  • Maria C. Passarelli

    (Memorial Sloan Kettering Cancer Center
    Rockefeller University and Sloan Kettering Institute)

  • Lauren Fairchild

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Carolina Adura

    (The Rockefeller University)

  • J. Fraser Glickman

    (The Rockefeller University)

  • Jessica Schulman

    (Memorial Sloan Kettering Cancer Center)

  • Christopher Famulare

    (Memorial Sloan Kettering Cancer Center)

  • Minal Patel

    (Memorial Sloan Kettering Cancer Center)

  • Joseph K. Eibl

    (Northern Ontario School of Medicine)

  • Gregory M. Ross

    (Northern Ontario School of Medicine)

  • Shibani Bhattacharya

    (New York Structural Biology Center, NMR Group)

  • Derek S. Tan

    (Memorial Sloan Kettering Cancer Center)

  • Christina S. Leslie

    (Memorial Sloan Kettering Cancer Center)

  • Thijs Beuming

    (Schrödinger, Inc.)

  • Dinshaw J. Patel

    (Memorial Sloan Kettering Cancer Center)

  • Yehuda Goldgur

    (Memorial Sloan Kettering Cancer Center)

  • John D. Chodera

    (Memorial Sloan Kettering Cancer Center)

  • Michael G. Kharas

    (Memorial Sloan-Kettering Cancer Center)

Abstract

The MUSASHI (MSI) family of RNA binding proteins (MSI1 and MSI2) contribute to a wide spectrum of cancers including acute myeloid leukemia. We find that the small molecule Ro 08–2750 (Ro) binds directly and selectively to MSI2 and competes for its RNA binding in biochemical assays. Ro treatment in mouse and human myeloid leukemia cells results in an increase in differentiation and apoptosis, inhibition of known MSI-targets, and a shared global gene expression signature similar to shRNA depletion of MSI2. Ro demonstrates in vivo inhibition of c-MYC and reduces disease burden in a murine AML leukemia model. Thus, we identify a small molecule that targets MSI’s oncogenic activity. Our study provides a framework for targeting RNA binding proteins in cancer.

Suggested Citation

  • Gerard Minuesa & Steven K. Albanese & Wei Xie & Yaniv Kazansky & Daniel Worroll & Arthur Chow & Alexandra Schurer & Sun-Mi Park & Christina Z. Rotsides & James Taggart & Andrea Rizzi & Levi N. Naden &, 2019. "Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia," Nature Communications, Nature, vol. 10(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10523-3
    DOI: 10.1038/s41467-019-10523-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-10523-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-019-10523-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Tatiana Erazo & Chiara M. Evans & Daniel Zakheim & Karen L. Chu & Alice Yunsi Refermat & Zahra Asgari & Xuejing Yang & Mariana Silva Ferreira & Sanjoy Mehta & Marco Vincenzo Russo & Andrea Knezevic & , 2022. "TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma," Nature Communications, Nature, vol. 13(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10523-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.